MONTELEONE, Palmiero
 Distribuzione geografica
Continente #
NA - Nord America 30.957
AS - Asia 16.907
EU - Europa 8.568
SA - Sud America 1.651
AF - Africa 264
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 37
Totale 58.427
Nazione #
US - Stati Uniti d'America 30.672
HK - Hong Kong 5.694
SG - Singapore 4.701
CN - Cina 2.625
UA - Ucraina 2.100
IT - Italia 1.944
VN - Vietnam 1.470
BR - Brasile 1.175
DE - Germania 992
TR - Turchia 787
RU - Federazione Russa 683
IE - Irlanda 627
FR - Francia 618
KR - Corea 500
FI - Finlandia 496
SE - Svezia 475
IN - India 332
AR - Argentina 197
GB - Regno Unito 178
BD - Bangladesh 137
IQ - Iraq 117
JP - Giappone 111
CA - Canada 107
MX - Messico 97
EC - Ecuador 73
AT - Austria 67
ZA - Sudafrica 62
PK - Pakistan 61
ID - Indonesia 60
NL - Olanda 59
PL - Polonia 59
VE - Venezuela 50
CO - Colombia 47
ES - Italia 44
EU - Europa 35
MA - Marocco 35
AU - Australia 34
MY - Malesia 33
UZ - Uzbekistan 32
JO - Giordania 30
KE - Kenya 30
PH - Filippine 30
CL - Cile 28
SA - Arabia Saudita 28
BE - Belgio 25
EG - Egitto 25
PY - Paraguay 25
PE - Perù 24
TN - Tunisia 24
CZ - Repubblica Ceca 20
IL - Israele 20
NO - Norvegia 18
NP - Nepal 18
RO - Romania 17
BG - Bulgaria 16
DZ - Algeria 16
AE - Emirati Arabi Uniti 15
CH - Svizzera 15
LT - Lituania 15
UY - Uruguay 14
BO - Bolivia 13
ET - Etiopia 13
CR - Costa Rica 11
HU - Ungheria 11
PA - Panama 11
PT - Portogallo 11
SN - Senegal 11
AL - Albania 10
AZ - Azerbaigian 10
DO - Repubblica Dominicana 10
RS - Serbia 10
GR - Grecia 9
GT - Guatemala 9
LB - Libano 9
NG - Nigeria 9
NZ - Nuova Zelanda 9
PS - Palestinian Territory 9
HR - Croazia 8
IR - Iran 8
JM - Giamaica 8
KZ - Kazakistan 8
HN - Honduras 7
KG - Kirghizistan 7
OM - Oman 7
BN - Brunei Darussalam 6
GH - Ghana 6
MD - Moldavia 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
MN - Mongolia 5
AO - Angola 4
GE - Georgia 4
KW - Kuwait 4
LU - Lussemburgo 4
MK - Macedonia 4
EE - Estonia 3
GY - Guiana 3
IM - Isola di Man 3
Totale 58.342
Città #
Ann Arbor 6.775
Hong Kong 5.675
Woodbridge 2.664
Jacksonville 2.556
Singapore 2.431
Wilmington 2.307
Chandler 2.161
Princeton 1.910
Houston 1.713
San Jose 1.710
Ashburn 1.257
Dallas 1.103
Izmir 728
Council Bluffs 620
Dublin 620
Dong Ket 610
The Dalles 511
Nanjing 510
Andover 481
Lauterbourg 469
Boardman 365
Pellezzano 338
Beijing 333
Ho Chi Minh City 294
Moscow 244
Düsseldorf 241
Hanoi 207
Naples 205
Hebei 178
Fairfield 169
Shenyang 167
Pune 165
Norwalk 162
Mestre 160
Nanchang 157
Changsha 130
Los Angeles 130
Jiaxing 118
Frankfurt am Main 113
Milan 112
São Paulo 100
Tokyo 97
New York 94
Santa Clara 89
Seattle 85
Salerno 80
Tianjin 76
Washington 73
Rome 69
Redwood City 67
Munich 63
Nuremberg 59
Des Moines 55
Da Nang 54
San Nicola la Strada 50
Orem 49
Baghdad 46
Rio de Janeiro 46
Warsaw 45
San Diego 41
Brooklyn 38
Amsterdam 37
Chicago 35
Edinburgh 34
Helsinki 33
Belo Horizonte 32
Cambridge 31
Boston 30
San Francisco 30
Amman 28
Atlanta 28
Columbus 28
Dhaka 28
Tashkent 28
Toronto 28
Chennai 27
Dearborn 27
Nettuno 27
Haiphong 26
Hải Dương 25
Jinan 24
Guayaquil 23
Nairobi 23
Sant'Anastasia 23
Vienna 23
Brussels 22
Johannesburg 22
Montreal 22
Quito 22
Turin 22
Florence 21
London 21
Mumbai 21
Shanghai 21
Biên Hòa 20
Brasília 20
Guangzhou 20
Stockholm 20
Curitiba 19
Catania 18
Totale 43.164
Nome #
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. 1.271
Early traumatic experiences and eating disorders: A focus on the endogenous stress response system 645
Assenza di modulazione GABAergica sulla secrezione basale di prolattina e di GH nella schizofrenia cronica 466
Circadian rhythms and treatment implications in depression 459
No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene with anorexia nervosa or bulimia nervosa 438
Enhanced response of ghrelin to sham feeding in patients with anorexia nervosa 427
Accuracy of self-assessment of real-life functioning in schizophrenia 358
Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa 353
Ghrelin response to hedonic eating in underweight and short-term weight restored patients with anorexia nervosa 340
Significant Locus and Metabolic Genetic Correlations Revealed in Genome-Wide Association Study of Anorexia Nervosa 317
Health-related quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes 257
Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects 235
Serotonin transporter polymorphism and potential response to SSRIs in bulimia nervosa. 227
Physical exercise at night blunts the nocturnal increase of plasma melatonin levels in healthy humans 218
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 210
Melanocortin-4 receptor molecular scanning and pro-opiomelanocortin R236G variant screening in binge eating disorder 207
Appropriatezza clinica, strutturale e operativa nella prevenzione, diagnosi e terapia dei disturbi dell’alimentazione 206
Childhood trauma and cortisol awakening response in symptomatic patients with anorexia nervosa and bulimia nervosa 198
A 4-year epidemiological study of typical and atypical eating disorders: preliminary evidence for subgroups of atypical eating disorders with different natural outcomes 184
Altered processing of rewarding and aversive basic taste stimuli in symptomatic women with anorexia nervosa and bulimia nervosa: An fMRI study 183
The human pineal gland responds to stress-induced sympathetic activation in the second half of the dark phase: preliminary evidence 180
3111T/C polymorphism of the clock gene confers a predisposition to a lifetime lower body weight in anorexia and bulimia nervosa 170
An epidemiological study on eating disorders in two high schools in Naples 167
Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa 165
Lateralization patterns of verbal stimuli processing assessed by reaction time and event-related potentials in schizophrenic patients 164
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 164
Altered immunoreactive levels of G proteins in peripheral mononuclear cells of patients with anorexia nervosa and bulimia nervosa 162
Serotonergic modulation of rat pineal gland activity: in vivo evidence for a 5-Hydroxytryptamine(2C) receptor involvement 159
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa 159
Regolazione del comportamento alimentare e correlati biochimici dell’anoressia e bulimia nervosa 157
Alterazioni neuroendocrine nella depressione stagionale 154
(+)-N-allylnormetazocine enhances N-acetyltransferase activity and melatonin synthesis: preliminary evidence for a functional role of sigma receptors in the rat pineal gland 154
The family of a patient with an eating disorder 151
Differences between morning and afternoon hormonal responses to D-fenfluramine in healthy humans 151
Growth hormone response to GABA?B receptor activation in depressed patients before and after antidepressant therapy 150
Aggressive behavioral characteristics and endogenous hormones in women with Bulimia nervosa 149
[Evaluation of therapeutic efficacy and pharmacokinetics of controlled release of trazodone in patients with major depressive disorder] 149
Chronic antidepressant drug treatment does not affect GH response to baclofen in depressed subjects 149
The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder 148
Serotonin Trasporter Polymorphisms And Ssri Response In Bulimia Nervosa 145
Interhemispheric functional connectivity in anorexia and bulimia nervosa 145
Correlations between negative symptoms and peripheral G protein levels in mononuclear leukocytes of deficit and nondeficit schizophrenics. Preliminary results 144
A comparative study of melatonin production in the retina, pineal gland and harderian gland of Bufo viridis and Rana esculenta 144
Evidence that cholinergic receptors of muscarinic type may modulate vasopressin release induced by metoclopramide 144
Are antipsychotics useful in the treatment of anorexia nervosa? 143
Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine 143
Evidence for opiate and estrogen interaction on neurohormonal secretion 143
The treatment of unipolar depression by lithium salts 141
Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder 141
Neuroendocrine effect of short term activation of GABAergic system in schizophrenics with and without tardive dyskinesia 140
The circadian basis of mood disorders: Recent developments and treatment implications 140
Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect 140
A genome-wide association study of anorexia nervosa suggests a risk locus implicated in dysregulated leptin signaling 140
NEUROENDOCRINOLOGY OF EATING DISORDERS: RECENT ADVANCES AND FUTURE PERSPECTIVES 139
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study. 139
Psychobiology of eating disorders 138
Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia 138
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. 138
Naloxone-induced decrease of plasma prolactin in healthy women 137
Combined alpha-adrenergic stimulation results in biphasic response of growth hormone release in man 136
Brain-derived neurtrophic factor in mood disorders: reply to Kapczinski et al.’s comment 135
The acute salivary ghrelin response to a psychosocial stress is enhanced in symptomatic patients with bulimia nervosa: a pilot study. 134
Differences in Cortisol Awakening Response between Binge-Purging and Restrictive Patients with Anorexia Nervosa 134
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia a network analysis 134
Development and validation of the family coping questionnaire for eating disorders 133
Underweight subjects with anorexia nervosa have an enhanced salivary cortisol response not seen in weight restored subjects with anorexia nervosa 133
PLASMA LEPTIN AND WEIGHT GAIN DURINO CLOZAPINE TREATMENT 132
Effect of pharmacological activation of gamma?aminobutyric acid system on basal pituitary secretion in humans 132
The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia 132
Circulating ghrelin is decreased in non-obese and obese women with binge eating disorder as well as in obese non-binge eating women, but not in patients with bulimia nervosa 131
Impulsiveness in patients with bulimia nervosa: electrophysiological evidence of reduced inhibitory control. 131
Test alla d-fenfluramina e risposta al trattamento farmacologico nei pazienti con sindrome ossessivo-compulsiva 131
Psicobiologia dei disturbi del comportamento alimentare 131
Association between A218C polymorphism of the tryptophan-hydroxylase-1 gene, harm avoidance and binge eating behavior in bulimia nervosa 130
Self-injurious behavior and attempted suicide in purging bulimia nervosa: Associations with psychiatric comorbidity 130
Risposta della prolattina alla d-fenfluramina in pazienti con sindrome ossessivo-compulsiva prima e dopo terapia con fluvoxamina 130
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity 130
Asymmetry of salivary cortisol and α-amylase responses to psychosocial stress in anorexia nervosa but not in bulimia nervosa 129
Plasma melatonin and cortisol circadian patterns in patients with obsessive-compulsive disorder before and after fluoxetine treatment 129
Effects of single and repeated electroconvulsive shock on isoproterenol-stimulated pineal N-acetyltransferase activity and melatonin production in rats 129
How do relatives cope with eating disorders? Results from an Italian multicentre study 129
Circadian Rhythm disturbances in depression: implications for treatment and quality of remission 128
G-PROTEIN IMMUNOREACTIVITY LEVELS IN LYMPHOCYTES OF DEFICIT AND NONDEFICIT SCHIZOPHRENIC PATIENTS 128
Association of a functional serotonin transporter gene polymorphism with binge eating disorder 128
PERIPHERAL NEUROSTEROID CONCENTRATIONS IN EATING DISORDERS 127
Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients 127
Anoressia e Bulimia Nervosa - NOOS 127
2-[125]Iodomelatonin binding sites in the brain retina and Harderian gland of the green frog Rana esculenta 127
Biological background of the psychological effects of cognitive-behavioural therapy in anorexia nervosa 126
Acute trazodone administration decreases plasma cortisol levels in healthy subjects. 126
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 126
Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake. 124
Leptin functioning in eating disorders 124
Changes in magnocellular neurosecretory activity following septal forebrain lesions: morphological and biochemical data 123
Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans 123
Leptin production in bulimia nervosa 123
INVESTIGATION OF NEUROACTIVE STEROIDS IN ANOREXIA AND BULIMIA NERVOSA 123
Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics 123
Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment 123
Brain-derived neurotrophic factor (BDNF) and eating behaviour in bulimia nervosa and binge eating disorder 123
Totale 18.297
Categoria #
all - tutte 189.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.287 0 0 0 0 0 0 0 0 0 30 483 774
2021/20223.332 9 4 18 29 36 22 50 129 517 439 445 1.634
2022/20235.458 616 249 224 479 786 1.162 23 607 737 39 405 131
2023/20242.575 226 332 174 78 153 420 147 241 42 158 201 403
2024/20254.338 328 78 131 148 164 561 610 704 672 194 355 393
2025/202619.168 1.384 2.949 3.484 666 2.189 1.243 3.609 717 1.043 1.884 0 0
Totale 59.606